Mini Oral Session 4

S REDZEPAGIC1, C. HUANG1, S. GLASTRAS1, 2, C. POLLOCK1, U. PANCHAPAKESAN1  1Renal Research Group, Kolling Institute, Royal North Shore Hospital, University of Sydney, Sydney, New South Wales; 2Department of Diabetes, Endocrinology and Metabolism, Royal North Shore Hospital, Sydney, New South Wales...
  • 4 August 2017
Read More
A K FOTHERINGHAM1,2 , S M SOLON-BIET3, 4,9, A C MCMAHON3,5,9,W O BALLARD6, K RUOHONEN7,  D J BORG1, 2 , D RAUBENHEIMER3,8, D G. LE COUTEUR3, 5, 9, S J SIMPSON3, 4, J M FORBES1,2 1Mater Research-UQ, Woolloongabba, QLD, Australia; 2University...
  • 4 August 2017
Read More
PS SAGAR1, M LUCIUK1, C MANNIX1, J ZHANG1, ATY WONG1, GK RANGAN1,2 1Centre for Transplant and Renal Research, Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales; 2Department of Renal Medicine, Westmead Hospital, Sydney, New South Wales....
  • 4 August 2017
Read More
X WANG1,2, AJ KASSIANOS1,2,3,4, K KILDEY1,2, J POTRIQUET5,  R WILKINSON1,2,3,4 and H HEALY1,2 1Conjoint Kidney Laboratory, Pathology Queensland, Brisbane, Queensland; 2Kidney Health Service, Royal Brisbane and Women’s Hospital, Brisbane, Queensland; 3Queensland University of Technology, Brisbane, Queensland; 4Medical School, University of Queensland, Brisbane, Queensland; 5QIMR...
  • 4 August 2017
Read More
Y SHI1, CL HUANG1, XM CHEN1, C POLLOCK1 1Kolling Institute, University of Sydney, Royal North Shore Hospital, Sydney, New South Wales Aim: To define the role of RIPK1 inhibition in alleviating renal fibrogenesis. Background: Current therapies for renal fibrosis are...
  • 4 August 2017
Read More
Categories